New Two-Pronged attack tested for Tough-to-Treat colon cancer
Disease control
Ongoing
This small, early-stage study is testing a new treatment approach for people with advanced colorectal cancer that has not spread to the liver, bones, or brain. Participants first receive a combination of two immunotherapy drugs. If their cancer grows, standard chemotherapy is add…
Phase: PHASE2 • Sponsor: Nicholas DeVito, MD • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC